← Open Payments lookup

SAID JACOB: Open Payments

NPI 1528128949 · GLENDORA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$197,592 in 438 payments from 16 companies in 2025. Trend: 2023 $206,351 · 2024 $190,936 · 2025 $197,592

Speaker / faculty: $153,677Consulting: $26,212Food & beverage: $11,341Travel & lodging: $6,362
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.92$72,656
Neurocrine BioSciences, Inc.88$47,801
Otsuka America Pharmaceutical, Inc.56$32,245
Alkermes, Inc.51$21,476
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)38$13,951
ABBVIE INC.34$5,187
E.R. Squibb & Sons, L.L.C.21$1,961
Axsome Therapeutics, Inc.17$944
Vanda Pharmaceuticals Inc.21$651
Alpha Cognition USA, Inc.7$303

Products named: INGREZZA, AUSTEDO XR, REXULTI, UZEDY, LYBALVI, CAPLYTA, VRAYLAR, ABILIFY MAINTENA.

Industry payments across CA — which companies pay providers there.